New hepatitis data highlight need for urgent global response
New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.
More From Around the Web
Check out these Articles
- Dutch gene therapy pioneer raises $82 mln in U.S. IPO
- Pharma Wholesale and Distribution Industry and Market: World Outlooks and F...
- Deaths reveal new world of drug dealing
- Unprecedented progress against neglected tropical diseases, WHO reports
- 9th Global conference on health promotion: Global leaders agree to promote ...
- Rick Perry, of All People, Backs Decriminalizing Marijuana
- Novartis, Valeant bids herald new deal-making era for pharma
- Fifth meeting of the Emergency Committee under the International Health Reg...
- First US recreational pot industry opens in Colorado, kicking off global ma...
- Beating the poppy seed defense: New test can distinguish heroin use from se...
- From coast to coast: Africa unites to tackle threat of polio
- Slow starts ends in victory at Pro (pics)
- Drug den napuhag, 11 ka tawo tiklo
- Julia Roberts' Half-Sister Nancy Motes Dies of Apparent Drug Overdose
- WHO welcomes global health funding for malaria vaccine
- #PreMarket Primer: Monday, April 7: World Bank Lowers China’s 2014 Gr...
- WHO urges end to tuberculosis